Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4346373
[patent_doc_number] => 06284760
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Method of treating schizophrenia, depression and other neurological conditions'
[patent_app_type] => 1
[patent_app_number] => 9/331185
[patent_app_country] => US
[patent_app_date] => 1999-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1607
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284760.pdf
[firstpage_image] =>[orig_patent_app_number] => 331185
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/331185 | Method of treating schizophrenia, depression and other neurological conditions | Jun 23, 1999 | Issued |
Array
(
[id] => 4072418
[patent_doc_number] => 06069154
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-30
[patent_title] => 'Methods for treating gastro-esophageal reflux disease using optically pure (+) cisapride'
[patent_app_type] => 1
[patent_app_number] => 9/336602
[patent_app_country] => US
[patent_app_date] => 1999-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7662
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/069/06069154.pdf
[firstpage_image] =>[orig_patent_app_number] => 336602
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/336602 | Methods for treating gastro-esophageal reflux disease using optically pure (+) cisapride | Jun 20, 1999 | Issued |
Array
(
[id] => 4406784
[patent_doc_number] => 06232297
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-15
[patent_title] => 'Methods and compositions for treating inflammatory response'
[patent_app_type] => 1
[patent_app_number] => 9/333387
[patent_app_country] => US
[patent_app_date] => 1999-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 13115
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/232/06232297.pdf
[firstpage_image] =>[orig_patent_app_number] => 333387
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/333387 | Methods and compositions for treating inflammatory response | Jun 14, 1999 | Issued |
Array
(
[id] => 4201630
[patent_doc_number] => 06077538
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-20
[patent_title] => 'Controlled release tablet compositions'
[patent_app_type] => 1
[patent_app_number] => 9/333380
[patent_app_country] => US
[patent_app_date] => 1999-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6054
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/077/06077538.pdf
[firstpage_image] =>[orig_patent_app_number] => 333380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/333380 | Controlled release tablet compositions | Jun 14, 1999 | Issued |
Array
(
[id] => 4101700
[patent_doc_number] => 06066654
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride'
[patent_app_type] => 1
[patent_app_number] => 9/329328
[patent_app_country] => US
[patent_app_date] => 1999-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7662
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066654.pdf
[firstpage_image] =>[orig_patent_app_number] => 329328
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/329328 | Methods for treating disorders associated with the central nervous system using optically pure (-) cisapride | Jun 9, 1999 | Issued |
Array
(
[id] => 4206157
[patent_doc_number] => 06077838
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-20
[patent_title] => 'Method of treating hangover'
[patent_app_type] => 1
[patent_app_number] => 9/327736
[patent_app_country] => US
[patent_app_date] => 1999-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1852
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/077/06077838.pdf
[firstpage_image] =>[orig_patent_app_number] => 327736
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/327736 | Method of treating hangover | Jun 7, 1999 | Issued |
Array
(
[id] => 4383960
[patent_doc_number] => 06277884
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Treatment of sexual dysfunction with N-hydroxyguanidine compounds'
[patent_app_type] => 1
[patent_app_number] => 9/321584
[patent_app_country] => US
[patent_app_date] => 1999-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 10993
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277884.pdf
[firstpage_image] =>[orig_patent_app_number] => 321584
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/321584 | Treatment of sexual dysfunction with N-hydroxyguanidine compounds | May 27, 1999 | Issued |
09/320769 | METHOD AND COMPOSITIONS FOR TREATING THE INFLAMMATORY RESPONSE | May 26, 1999 | Abandoned |
Array
(
[id] => 4090474
[patent_doc_number] => 06133316
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Use of nitric oxide inhibitors for treating side effects of particulate drugs'
[patent_app_type] => 1
[patent_app_number] => 9/318803
[patent_app_country] => US
[patent_app_date] => 1999-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 21
[patent_no_of_words] => 3978
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133316.pdf
[firstpage_image] =>[orig_patent_app_number] => 318803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/318803 | Use of nitric oxide inhibitors for treating side effects of particulate drugs | May 25, 1999 | Issued |
Array
(
[id] => 4360629
[patent_doc_number] => 06169115
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-02
[patent_title] => 'Use of aminoguanidine analogs for the treatment of diseases of the nervous system'
[patent_app_type] => 1
[patent_app_number] => 9/316489
[patent_app_country] => US
[patent_app_date] => 1999-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8103
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/169/06169115.pdf
[firstpage_image] =>[orig_patent_app_number] => 316489
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/316489 | Use of aminoguanidine analogs for the treatment of diseases of the nervous system | May 20, 1999 | Issued |
Array
(
[id] => 4220243
[patent_doc_number] => 06040307
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Methods ad compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections'
[patent_app_type] => 1
[patent_app_number] => 9/314229
[patent_app_country] => US
[patent_app_date] => 1999-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5083
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040307.pdf
[firstpage_image] =>[orig_patent_app_number] => 314229
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/314229 | Methods ad compositions of (-) ketoconazole for treating fungal yeast and dermatophyte infections | May 17, 1999 | Issued |
Array
(
[id] => 4237831
[patent_doc_number] => 06166024
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Use of topical azathioprine and thioguanine to treat colorectal adenomas'
[patent_app_type] => 1
[patent_app_number] => 9/310505
[patent_app_country] => US
[patent_app_date] => 1999-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4047
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/166/06166024.pdf
[firstpage_image] =>[orig_patent_app_number] => 310505
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/310505 | Use of topical azathioprine and thioguanine to treat colorectal adenomas | May 11, 1999 | Issued |
Array
(
[id] => 4129759
[patent_doc_number] => 06121010
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Methods and assays useful in the treatment of alcohol dependence or alcohol abuse'
[patent_app_type] => 1
[patent_app_number] => 9/310614
[patent_app_country] => US
[patent_app_date] => 1999-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6472
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/121/06121010.pdf
[firstpage_image] =>[orig_patent_app_number] => 310614
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/310614 | Methods and assays useful in the treatment of alcohol dependence or alcohol abuse | May 11, 1999 | Issued |
Array
(
[id] => 1485603
[patent_doc_number] => 06365573
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Regulation of neural enzymes'
[patent_app_type] => B1
[patent_app_number] => 09/269907
[patent_app_country] => US
[patent_app_date] => 1999-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4670
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365573.pdf
[firstpage_image] =>[orig_patent_app_number] => 09269907
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269907 | Regulation of neural enzymes | May 9, 1999 | Issued |
Array
(
[id] => 4103726
[patent_doc_number] => 06100269
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-08
[patent_title] => 'Pharmaceutical compositions for prevention and treatment of central nervous system disorders'
[patent_app_type] => 1
[patent_app_number] => 9/306497
[patent_app_country] => US
[patent_app_date] => 1999-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14767
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/100/06100269.pdf
[firstpage_image] =>[orig_patent_app_number] => 306497
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/306497 | Pharmaceutical compositions for prevention and treatment of central nervous system disorders | May 5, 1999 | Issued |
Array
(
[id] => 4346930
[patent_doc_number] => 06284794
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase'
[patent_app_type] => 1
[patent_app_number] => 9/304115
[patent_app_country] => US
[patent_app_date] => 1999-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 42173
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284794.pdf
[firstpage_image] =>[orig_patent_app_number] => 304115
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/304115 | Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase | May 3, 1999 | Issued |
09/302379 | METHOD FOR TREATING ASTHMA USING OPTICALLY PURE R(-) SALMETEROL | Apr 29, 1999 | Abandoned |
Array
(
[id] => 4238220
[patent_doc_number] => 06166048
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-26
[patent_title] => 'Pharmaceutical compositions for inhibition of cytokine production and secretion'
[patent_app_type] => 1
[patent_app_number] => 9/295181
[patent_app_country] => US
[patent_app_date] => 1999-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20745
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/166/06166048.pdf
[firstpage_image] =>[orig_patent_app_number] => 295181
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/295181 | Pharmaceutical compositions for inhibition of cytokine production and secretion | Apr 19, 1999 | Issued |
Array
(
[id] => 7105495
[patent_doc_number] => 20010004637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-06-21
[patent_title] => 'STABLE MEDICINAL COMPOSITIONS CONTAINING 4,5-EPOXYMORPHINANE DERIVATIVES'
[patent_app_type] => new-utility
[patent_app_number] => 09/254650
[patent_app_country] => US
[patent_app_date] => 1999-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6841
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20010004637.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254650 | Stable medicinal compositions containing 4,5-epoxymorphinan derivatives | Apr 18, 1999 | Issued |
Array
(
[id] => 4296391
[patent_doc_number] => 06197820
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Use of phenylglycine derivatives to decrease neuronal death caused by brain tumors and brain lesions'
[patent_app_type] => 1
[patent_app_number] => 9/292029
[patent_app_country] => US
[patent_app_date] => 1999-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 27
[patent_no_of_words] => 10130
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197820.pdf
[firstpage_image] =>[orig_patent_app_number] => 292029
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/292029 | Use of phenylglycine derivatives to decrease neuronal death caused by brain tumors and brain lesions | Apr 15, 1999 | Issued |